IP Library Patent Application 17576636
Patent Application
App. No. 17/576,636

HIGHLY PORTABLE NEGATIVE-PRESSURE WOUND CLOSURESYSTEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/576,636
Abstract

An ultra-portable therapy system for treating a tissue site with negative pressure is disclosed. In some embodiments, the therapy system may include a wound dressing, a low-profile conduit, a therapy unit, and a communications device. Some embodiments may also include aspects of a therapy network, including communications networks and a remote monitoring center.

Claims (65)

1 . An apparatus for treating a tissue site, comprising:

a therapy unit comprising:

a pneumatic pump,

a first processor operatively coupled to the pneumatic pump, the first processor configured to receive data from the pneumatic pump and generate operational data of the pneumatic pump, and

a first transceiver operatively coupled to the first processor, the first processor and the first transceiver configured to transmit the operational data of the pneumatic pump to a remote device;

wherein the remote device comprises a second transceiver configured to receive the operational data transmitted by the first transceiver, and a third transceiver configured to transmit the operational data to a monitoring center.

2 . The apparatus of claim 1 , wherein the fluid conduit comprises a flexible, non-woven material sealed between a plurality of occlusive layers. further comprising:

an absorbent wound dressing fluidly coupled to the therapy unit by a fluid conduit,

wherein the fluid conduit comprises a flexible, non-woven material sealed between a plurality of occlusive layers.

3 . The apparatus of claim 2 , wherein the plurality of occlusive layers comprises polyurethane.

4 . The apparatus of claim 2 , further comprising a connection interface configured to fluidly connect the fluid conduit to the absorbent wound dressing.

5 . The apparatus of claim 2 , wherein the fluid conduit comprises a low-profile conduit comprising a receiving end and a transmitting end separated by a length, the low-profile conduit further comprising:

a manifold comprising a plurality of fibers defining a plurality of fluid communication voids through the manifold, and

a sealing member encapsulating the manifold between the receiving end and the transmitting end.

6 . The apparatus of claim 5 , wherein the plurality of fibers are adapted to engage one another when the low-profile conduit is exposed to a force, and wherein the fluid communication voids are adapted to provide fluid communication through the low-profile conduit when exposed to the force.

7 . The apparatus of claim 5 , further comprising a conduit interface adapted to be fluidly coupled to the receiving end of the low-profile conduit.

8 . The apparatus of claim 5 , wherein the plurality of fibers comprises a plurality of longitudinal fibers oriented substantially in a longitudinal direction along the length of the low-profile conduit.

9 . The apparatus of claim 5 , wherein the plurality of fibers comprises a plurality of vertical fibers oriented substantially normal relative to the length of the low-profile conduit.

10 . The apparatus of claim 5 , wherein the plurality of fibers comprises:

a plurality of longitudinal fibers oriented substantially in a longitudinal direction along the length of the low-profile conduit; and

a plurality of vertical fibers oriented substantially normal relative to the longitudinal fibers;

wherein the longitudinal fibers and the vertical fibers are adapted to engage one another when the low-profile conduit is exposed to a force, and wherein the plurality of fluid communication voids are adapted to provide fluid communication through the low-profile conduit when exposed to the force.

11 . The apparatus of claim 5 , wherein the length of the fluid conduit does not include a tube.

12 . The apparatus of claim 5 , wherein the sealing member further comprises a first sealing layer and a second sealing layer, wherein the second sealing layer includes an adhesive layer on an external, tissue-facing surface.

13 . The apparatus of claim 1 , wherein the absorbent wound dressing comprises:

a tissue interface adapted to be placed proximate to the tissue site; and

a cover adapted to be placed over the tissue interface.

14 . The apparatus of claim 13 , wherein the absorbent wound dressing further comprises an absorbent layer having a superabsorbent material.

15 . The apparatus of claim 1 , wherein the therapy unit further comprises a battery supply, wherein the first processor and the first transceiver are configured to transmit a status of the battery supply, wherein the second processor and the second transceiver are configured to receive the status of the battery supply, and wherein the second processor and the display screen are configured to display an alert on the display screen in response to the status of the battery supply indicating a charge level of the battery decreasing below a threshold.

16 . The apparatus of claim 1 , wherein the remote device further comprises a user input, wherein the second processor and the second transceiver are configured to transmit a stop signal in response to a command received from the user input, wherein the first transceiver is configured to receive the stop signal, and wherein the first processor is configured to deactivate the pneumatic pump in response to the first transceiver receiving the stop signal.

17 . The apparatus of claim 1 , wherein the second processor and the display screen are configured to display an alert related to a fluid flow indicated by the operational data.

18 . The apparatus of claim 1 , wherein the therapy unit further comprises an integrated inductive coil adapted to provide a charge to a power supply of the therapy unit.

19 . A method for treating a tissue site, comprising:

applying an absorbent dressing to the tissue site;

fluidly connecting the absorbent dressing to a therapy unit comprising:

a pneumatic pump,

a first processor operatively coupled to the pneumatic pump, and

a first transceiver operatively coupled to the first processor;

activating the therapy unit to provide a reduced pressure to the absorbent dressing;

receiving, at the first processor, operational data from the pneumatic pump;

generating, at the first processor, usage data of the pneumatic pump;

transmitting, from the first transceiver, usage data of the pneumatic pump;

receiving, at a second transceiver of a remote electronic device, the transmitted usage data of the therapy unit;

transmitting, from a third transceiver of the remote electronic device, the transmitted usage data of the therapy unit; and

receiving, at a monitoring center, the transmitted usage data of the therapy unit.

20 . The method of claim 19 , further comprising providing one or more user inputs to the remote electronic device and transmitting the one or more user inputs to the therapy unit to remotely control the therapy unit.

21 . The method of claim 19 , further comprising transmitting the usage data from the remote electronic device through a communications network to a remote monitoring apparatus.

22 . The method of claim 21 , further comprising remotely troubleshooting one or more identified issues with the therapy unit or absorbent dressing based on the transmitted usage data.

23 . The method of claim 19 , further comprising exchanging the therapy unit with a replacement therapy unit.

24 . The method of claim 23 , wherein the therapy unit is exchanged with the replacement therapy unit at an interval of approximately 3-10 days.

25 . The method of claim 23 , wherein the therapy unit is exchanged with the replacement therapy unit at an interval of approximately 6-8 days.

26 . The method of claim 23 , wherein the therapy unit is exchanged with the replacement therapy unit following a low battery status indication on the therapy unit.

27 . The method of claim 23 , wherein the therapy unit is exchanged without removing the absorbent dressing.

28 . A therapy unit for treating a tissue site, comprising:

a negative-pressure source; and

a processor operatively coupled to the negative-pressure source, the processor configured to:

receive input information related to delivery of negative pressure from the negative-pressure source to the tissue site,

generate output information related to delivery of negative pressure from the negative-pressure source to the tissue site, and

transmit the output information from a first transceiver of the therapy unit to a mobile device via a first network, the first network adapted to allow communications between the first transceiver of the therapy unit and a second transceiver of the mobile device;

wherein the mobile device adapted to:

receive, at the second transceiver of the mobile device, the output information,

display information related to the delivery of negative pressure from the negative-pressure source to the tissue site,

collect instructions from a user related to operational parameters of the therapy unit, and

transmit the output information from a third transceiver of the mobile device to a monitoring center via a second network, the second network adapted to allow communications between the third transceiver of the mobile device and the monitoring center.

29 . The therapy unit of claim 28 , wherein the input information comprises the instructions from the user communicated from the mobile device.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066431/0915 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2024
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 066064/0128 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2023
From: KIESWETTER, KRISTINE M.; MARCROFT, MICHAEL; LOCKE, CHRISTOPHER BRIAN
To: KCI LICENSING, INC.
Reel/Frame 064792/0364 →